Co-dydramol: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
== Co-dydramol == | |||
[[File:Dihydrocodeine_and_paracetamol.svg|thumb|right|Chemical structure of Dihydrocodeine and Paracetamol]] | |||
'''Co-dydramol''' is a combination analgesic medication used for the relief of moderate pain. It contains two active ingredients: [[dihydrocodeine]] and [[paracetamol]] (also known as acetaminophen). This combination is designed to provide enhanced pain relief compared to either component alone. | |||
== | == Composition and Mechanism of Action == | ||
Co-dydramol is composed of dihydrocodeine, an opioid analgesic, and paracetamol, a non-opioid analgesic. Dihydrocodeine works by binding to [[opioid receptors]] in the central nervous system, altering the perception of pain and emotional response to pain. Paracetamol, on the other hand, is believed to inhibit the synthesis of [[prostaglandins]] in the brain, which are chemicals that can cause pain and inflammation. | |||
Co-dydramol | |||
== | == Indications == | ||
== | Co-dydramol is indicated for the relief of moderate pain that is not controlled by paracetamol, ibuprofen, or aspirin alone. It is often prescribed for conditions such as [[osteoarthritis]], [[rheumatoid arthritis]], and other musculoskeletal disorders. It may also be used for post-operative pain management. | ||
== Dosage and Administration == | |||
The dosage of co-dydramol is typically determined by the severity of the pain and the patient's response to the medication. It is usually taken orally, with or without food. Patients are advised to follow the prescribed dosage and not to exceed the recommended amount to avoid the risk of [[paracetamol toxicity]] and opioid-related side effects. | |||
== Side Effects == | |||
Common side effects of co-dydramol include [[nausea]], [[vomiting]], [[constipation]], and [[drowsiness]]. More serious side effects can occur, such as [[respiratory depression]], especially if taken in higher doses or in combination with other central nervous system depressants. Patients should be monitored for signs of [[addiction]] or [[dependence]] due to the opioid component. | |||
== Contraindications == | |||
Co-dydramol is contraindicated in patients with known hypersensitivity to dihydrocodeine, paracetamol, or any other component of the formulation. It should not be used in patients with severe [[respiratory depression]], [[acute asthma]], or [[paralytic ileus]]. Caution is advised in patients with [[liver disease]] or [[renal impairment]]. | |||
== Related Pages == | |||
* [[Dihydrocodeine]] | |||
* [[Paracetamol]] | * [[Paracetamol]] | ||
* [[ | * [[Opioid analgesics]] | ||
* [[Pain management]] | |||
* [[ | |||
[[Category:Analgesics]] | [[Category:Analgesics]] | ||
[[Category:Combination drugs]] | [[Category:Combination drugs]] | ||
Latest revision as of 06:11, 16 February 2025
Co-dydramol[edit]

Co-dydramol is a combination analgesic medication used for the relief of moderate pain. It contains two active ingredients: dihydrocodeine and paracetamol (also known as acetaminophen). This combination is designed to provide enhanced pain relief compared to either component alone.
Composition and Mechanism of Action[edit]
Co-dydramol is composed of dihydrocodeine, an opioid analgesic, and paracetamol, a non-opioid analgesic. Dihydrocodeine works by binding to opioid receptors in the central nervous system, altering the perception of pain and emotional response to pain. Paracetamol, on the other hand, is believed to inhibit the synthesis of prostaglandins in the brain, which are chemicals that can cause pain and inflammation.
Indications[edit]
Co-dydramol is indicated for the relief of moderate pain that is not controlled by paracetamol, ibuprofen, or aspirin alone. It is often prescribed for conditions such as osteoarthritis, rheumatoid arthritis, and other musculoskeletal disorders. It may also be used for post-operative pain management.
Dosage and Administration[edit]
The dosage of co-dydramol is typically determined by the severity of the pain and the patient's response to the medication. It is usually taken orally, with or without food. Patients are advised to follow the prescribed dosage and not to exceed the recommended amount to avoid the risk of paracetamol toxicity and opioid-related side effects.
Side Effects[edit]
Common side effects of co-dydramol include nausea, vomiting, constipation, and drowsiness. More serious side effects can occur, such as respiratory depression, especially if taken in higher doses or in combination with other central nervous system depressants. Patients should be monitored for signs of addiction or dependence due to the opioid component.
Contraindications[edit]
Co-dydramol is contraindicated in patients with known hypersensitivity to dihydrocodeine, paracetamol, or any other component of the formulation. It should not be used in patients with severe respiratory depression, acute asthma, or paralytic ileus. Caution is advised in patients with liver disease or renal impairment.